Lipid parameter thresholds: The debate continues

Abstract

Get full access to this article

View all access options for this article.

References

World Health Organization. World health statistics. Geneva: World Health Organization, https://apps.who.int/infobase/ (2019, accessed 27 March 2019).

Grundy

Stone

Bailey

, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: Executive summary. Circulation. Epub ahead of print 10 November 2018. DOI: 10.1161/CIR.0000000000000624.

Piepoli

Hoes

Agewall

, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Prev Cardiol 2016; 23: NP1–NP96.

Ferrieres

de Ferrari

Hermans

, et al. Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe. Eur J Prev Cardiol 2018; 25: 1966–1976.

Poh

Ambegaonkar

Baxter

, et al. Low-density lipoprotein cholesterol target attainment in patients with stable or acute coronary heart disease in the Asia-Pacific region: Results from the Dyslipidemia International Study II. Eur J Prev Cardiol 2018; 25: 1950–1963.

Wang

Yan

Tomlison

, et al. Is lipid goal one-size-fits-all: A review of evidence for recommended low-density lipoprotein treatment targets in Asian patients. Eur J Prev Cardiol. 2019; 26: 1496–1506.

Critchley

Liu

Zhao

, et al. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation 2004; 110: 1236–1244.

Ogata

Nishimura

Guzman-Castillo

, et al. Explaining the decline in coronary heart disease mortality rates in Japan: Contributions of changes in risk factors and evidence-based treatments between 1980 and 2012. Int J Cardiol 2019. pii: S0167-5273(18)34148-2. DOI: 10.1016/j.ijcard.2019.02.022.

Garcia-Gil

Comas-Cufí

Blanch

, et al. Effectiveness of statins as primary prevention in people with different cardiovascular risk: A population-based cohort study. Clin Pharmacol Ther 2018; 104: 719–732.

10.

Ramos

Comas-Cufí

Martí-Lluch

, et al. Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study. BMJ 2018; 362: k3359–k3359.